LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 1 | 87.86 | 84.90 | 111 | 7680 | 0.0145 | 0.0421 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 87.86 | 84.90 | 1084 | 7680 | 0.1411 | 0.4798 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 87.86 | 84.90 | 1070 | 7680 | 0.1393 | 0.4768 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 87.86 | 84.90 | 1254 | 7680 | 0.1633 | 0.5133 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 89.57 | 84.90 | 119 | 7494 | 0.0159 | 0.0536 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 89.57 | 84.90 | 1111 | 7494 | 0.1482 | 0.4886 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 89.57 | 84.90 | 983 | 7494 | 0.1312 | 0.4607 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 89.57 | 84.90 | 1198 | 7494 | 0.1599 | 0.5061 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 91.27 | 84.90 | 108 | 7420 | 0.0146 | 0.0380 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 91.27 | 84.90 | 1114 | 7420 | 0.1501 | 0.4905 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 91.27 | 84.90 | 1001 | 7420 | 0.1349 | 0.4660 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 91.27 | 84.90 | 1219 | 7420 | 0.1643 | 0.5115 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 92.98 | 84.90 | 127 | 7257 | 0.0175 | 0.0648 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 92.98 | 84.90 | 1121 | 7257 | 0.1545 | 0.4950 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 92.98 | 84.90 | 1018 | 7257 | 0.1403 | 0.4727 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 92.98 | 84.90 | 1236 | 7257 | 0.1703 | 0.5179 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 94.68 | 84.90 | 121 | 7000 | 0.0173 | 0.0572 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 94.68 | 84.90 | 1244 | 7000 | 0.1777 | 0.5246 | MN20160318_Q02 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 94.68 | 84.90 | 967 | 7000 | 0.1381 | 0.4655 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 94.68 | 84.90 | 1232 | 7000 | 0.1760 | 0.5223 | MN20160318_Q02 | J12 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 2.66 | 84.90 | 750 | 285 | 2.6248 | 2.4705 | MN20160318_Q02 | J14 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 2.66 | 84.90 | 1 | 285 | 0.0035 | -0.9209 | MN20160318_Q02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 2.66 | 84.90 | 781 | 285 | 2.7333 | 2.5517 | MN20160318_Q02 | K04 |
MCF 10A-H2B-mCherry | Neratinib | 3.1623 | 4.36 | 84.90 | 1 | 322 | 0.0031 | -0.9004 | MN20160318_Q02 | J14 |